{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T10:32:59Z","timestamp":1784716379818,"version":"3.55.0"},"reference-count":40,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2015,8,11]],"date-time":"2015-08-11T00:00:00Z","timestamp":1439251200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0135516","type":"journal-article","created":{"date-parts":[[2015,8,11]],"date-time":"2015-08-11T17:58:14Z","timestamp":1439315894000},"page":"e0135516","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":3,"title":["Effects of Carbenoxolone on the Canine Pituitary-Adrenal Axis"],"prefix":"10.1371","volume":"10","author":[{"given":"Takahiro","family":"Teshima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotaka","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Okusa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidekazu","family":"Koyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,8,11]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"374","DOI":"10.2460\/javma.1998.212.03.374","article-title":"Efficacy of cobalt 60 radiotherapy in dogs with pituitary-dependent hyperadrenocorticism","volume":"212","author":"MM Goossens","year":"1998","journal-title":"J Am Vet Med Assoc"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0303-7207(02)00283-6","article-title":"Progress in transsphenoidal hypophysectomy for treatment of pituitary-dependent hyperadrenocorticism in dogs and cats","volume":"197","author":"B Meij","year":"2002","journal-title":"Mol Cell Endocrinol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1053\/j.tcam.2012.06.002","article-title":"Medical management of pituitary-dependent hyperadrenocorticism: mitotane versus trilostane","volume":"27","author":"NJ Reine","year":"2012","journal-title":"Top Companion Anim Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1365-2265.2005.02380.x","article-title":"Long-term remission rates after pituitary surgery for Cushing's disease: the need for long-term surveillance","volume":"63","author":"AB Atkinson","year":"2005","journal-title":"Clin Endocrinol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"6348","DOI":"10.1210\/jc.2003-032180","article-title":"Transsphenoidal microsurgery for Cushing's disease: initial outcome and long-term results","volume":"89","author":"GD Hammer","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0195-5616(97)50030-1","article-title":"Medical treatment of pituitary-dependent hyperadrenocorticism. Mitotane","volume":"27","author":"ME Peterson","year":"1997","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.cvsm.2009.10.008","article-title":"Trilostane in dogs","volume":"40","author":"IK Ramsey","year":"2010","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"269","DOI":"10.5326\/0420269","article-title":"Long-term efficacy of trilostane administered twice daily in dogs with pituitary-dependent hyperadrenocorticism","volume":"42","author":"DP Alenza","year":"2006","journal-title":"J Am Anim Hosp Assoc"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1111\/j.1939-1676.2005.tb02769.x","article-title":"A comparison of the survival times of dogs treated with mitotane or trilostane for pituitary-dependent hyperadrenocorticism","volume":"19","author":"EN Barker","year":"2005","journal-title":"J Vet Intern Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1136\/vr.159.9.277","article-title":"Study of the effects of once daily doses of trilostane on cortisol concentrations and responsiveness to adrenocorticotrophic hormone in hyperadrenocorticoid dogs","volume":"159","author":"R Bell","year":"2006","journal-title":"Vet Rec"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/j.1751-0813.2003.tb12498.x","article-title":"Trilostane treatment in dogs with pituitary-dependent hyperadrenocorticism","volume":"81","author":"JA Braddock","year":"2003","journal-title":"Aust Vet J"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1053\/j.ctsap.2007.02.003","article-title":"Medical management of pituitary-dependent hyperadrenocorticism: mitotane versus trilostane","volume":"22","author":"NJ Reine","year":"2007","journal-title":"Clin Tech Small Anim Pract"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.2460\/ajvr.1985.46.07.1534","article-title":"Effect of o,p'DDD therapy on endogenous ACTH concentrations in dogs with hypophysis-dependent hyperadrenocorticism","volume":"46","author":"RW Nelson","year":"1985","journal-title":"Am J Vet Res"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"854","DOI":"10.2460\/javma.1988.193.07.854","article-title":"Neurologic, endocrinologic, and pathologic findings associated with large pituitary tumors in dogs: eight cases (1976\u20131984)","volume":"193","author":"D Sarfaty","year":"1988","journal-title":"J Am Vet Med Assoc"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.domaniend.2008.10.002","article-title":"Trilostane-induced inhibition of cortisol secretion results in reduced negative feedback at the hypothalamic-pituitary axis","volume":"36","author":"T Teshima","year":"2009","journal-title":"Domest Anim Endocrinol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/cen.12345","article-title":"Efficacy of medical treatment in Cushing's disease: a systematic review","volume":"80","author":"MR Gadelha","year":"2014","journal-title":"Clin Endocrinol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s40265-013-0052-0","article-title":"Pasireotide: a review of its use in Cushing's disease","volume":"73","author":"K McKeage","year":"2013","journal-title":"Drugs"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1159\/000317716","article-title":"Medical treatment in Cushing's syndrome: dopamine agonists and cabergoline","volume":"92","author":"P Petrossians","year":"2010","journal-title":"Neuroendocrinology"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s40265-013-0067-6","article-title":"Recent developments in drug therapy for Cushing's disease","volume":"73","author":"R van der Pas","year":"2013","journal-title":"Drugs"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"4438","DOI":"10.1210\/en.2006-0414","article-title":"Retinoic acid as a novel medical therapy for Cushing's disease in dogs","volume":"147","author":"V Castillo","year":"2006","journal-title":"Endocrinology"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1159\/000327429","article-title":"Effect of SOM230 (pasireotide) on corticotropic cells: action in dogs with Cushing's disease","volume":"94","author":"V Castillo","year":"2011","journal-title":"Neuroendocrinology"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"4712","DOI":"10.1172\/JCI60417","article-title":"EGFR as a therapeutic target for human, canine, and mouse ACTH-secreting pituitary adenomas","volume":"121","author":"H Fukuoka","year":"2011","journal-title":"J Clin Invest"},{"key":"ref23","first-page":"2728","article-title":"Expression of 11 beta-hydroxysteroid dehydrogenase isoenzymes in the human pituitary: induction of the type 2 enzyme in corticotropinomas and other pituitary tumors","volume":"86","author":"M Korbonits","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1210\/en.2005-0544","article-title":"Inhibition of 11beta-hydroxysteroid dehydrogenase eliminates impaired glucocorticoid suppression and induces apoptosis in corticotroph tumor cells","volume":"147","author":"T Nigawara","year":"2006","journal-title":"Endocrinology"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1055\/s-2007-985142","article-title":"Quantitative real-time PCR for the measurement of 11beta-HSD1 and 11beta-HSD2 mRNA levels in tissues of healthy dogs","volume":"39","author":"NS Sieber-Ruckstuhl","year":"2007","journal-title":"Horm Metab Res"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.domaniend.2008.08.002","article-title":"Expression of genes related to corticotropin production and glucocorticoid feedback in corticotroph adenomas of dogs with Cushing's disease","volume":"36","author":"T Teshima","year":"2009","journal-title":"Domest Anim Endocrinol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1038\/sj.onc.1206293","article-title":"Abnormal expression of 11 beta-hydroxysteroid dehydrogenase type 2 in human pituitary adenomas: a prereceptor determinant of pituitary cell proliferation","volume":"22","author":"EH Rabbitt","year":"2003","journal-title":"Oncogene"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/j.1939-1676.2009.0328.x","article-title":"Accuracy of an adrenocorticotropic hormone (ACTH) immunoluminometric assay for differentiating ACTH-dependent from ACTH-independent hyperadrenocorticism in dogs","volume":"23","author":"MI Rodr\u00edguez Pi\u00f1eiro","year":"2009","journal-title":"J Vet Intern Med"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.domaniend.2005.12.009","article-title":"Acromegaly due to a somatroph adenoma in a dog","volume":"32","author":"F Fracassi","year":"2007","journal-title":"Domest Anim Endocrinol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.tvjl.2014.03.022","article-title":"Expression of 11\u03b2-hydroxysteroid dehydrogenase isoforms in canine adrenal glands treated with trilostane","volume":"200","author":"T Teshima","year":"2014","journal-title":"Vet J"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.2460\/ajvr.67.8.1385","article-title":"Effect of mitotane on pituitary corticotrophs in clinically normal dogs","volume":"67","author":"T Taoda","year":"2006","journal-title":"Am J Vet Res"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0016-5085(76)80550-1","article-title":"Effects of carbenoxolone on gastric mucosal permeability and blood flow in the dog","volume":"71","author":"MA Simons","year":"1976","journal-title":"Gastroenterology"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/BF03350002","article-title":"The pathogenesis of pseudohyperaldosteronism from carbenoxolone","volume":"12","author":"D Armanini","year":"1989","journal-title":"J Endocrinol Invest"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.tox.2011.04.007","article-title":"Environmental inhibitors of 11\u03b2-hydroxysteroid dehydrogenase type 2","volume":"285","author":"X Ma","year":"2011","journal-title":"Toxicology"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1440-1681.2011.05640.x","article-title":"Inhibition of 11\u03b2-hydroxysteroid dehydrogenase 1 by carbenoxolone affects glucose homeostasis and obesity in db\/db mice","volume":"39","author":"N Dhanesha","year":"2012","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"872","DOI":"10.2337\/diabetes.54.3.872","article-title":"Increased in vivo regeneration of cortisol in adipose tissue in human obesity and effects of the 11beta-hydroxysteroid dehydrogenase type 1 inhibitor carbenoxolone","volume":"54","author":"TC Sandeep","year":"2005","journal-title":"Diabetes"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1055\/s-0031-1297990","article-title":"Carbenoxolone alters the morphology of adipose tissues and downregulates genes involved in adipogenesis, glucose transport and lipid metabolism in high-fat diet-fed mice","volume":"44","author":"S Sano","year":"2012","journal-title":"Horm Metab Res"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1136\/gut.18.12.1054","article-title":"Changes in the plasma clearance and protein binding of carbenoxolone with age, and their possible relationship with adverse drug effects","volume":"18","author":"MJ Hayes","year":"1977","journal-title":"Gut"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1677\/joe.0.1030219","article-title":"Evidence for episodic but not circadian activity in plasma concentrations of adrenocorticotrophin, cortisol and thyroxine in dogs","volume":"103","author":"RJ Kemppainen","year":"1984","journal-title":"J Endocrinol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1677\/joe.0.1520113","article-title":"Pulsatile secretion of alpha-MSH and the differential effects of dexamethasone and haloperidol on the secretion of alpha-MSH and ACTH in dogs","volume":"152","author":"HS Kooistra","year":"1997","journal-title":"J Endocrinol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0135516","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T23:36:22Z","timestamp":1748561782000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0135516"}},"subtitle":[],"editor":[{"given":"Peyman","family":"Bj\u00f6rklund","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,8,11]]},"references-count":40,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2015,8,11]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0135516","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,11]]}}}